<DOC>
	<DOCNO>NCT00528112</DOCNO>
	<brief_summary>This study new low dose levonorgestrel contraceptive intrauterine system ( LCS ) . The purpose study investigate 2 administered dos lowest effective intrauterine dose Levonorgestrel ( LNG ) administer via LCS contraception 3 year . The study amend : LCS16 arm extend 5 year</brief_summary>
	<brief_title>Levonorgestrel Contraceptive Intrauterine Systems ( LCS ) Pearl Index Study</brief_title>
	<detailed_description>Drop out-rate cover Participant flow section .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Age 18 35 year ( inclusive ) , good general health request contraception . Has regular menstrual cycle ( length cycle 2135 day ) ( i.e. , endogenous cyclicity without hormonal contraceptive use ) . Known suspected pregnancy lactate . History ectopic pregnancy . Any genital infection ( successfully treat ) . Abnormal uterine bleed unknown origin .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Intrauterine</keyword>
	<keyword>IUD</keyword>
	<keyword>IUS</keyword>
</DOC>